Suppr超能文献

避免药物性肝损伤(DILI)在一个老年住院队列中,使用更新的 RUCAM 评分评估因果关系的病例。

Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score.

机构信息

Division of General Internal Medicine, Weill Cornell affiliated-Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.

Weill Cornell College of Medicine, New York and Doha, Qatar.

出版信息

BMC Geriatr. 2020 Sep 14;20(1):346. doi: 10.1186/s12877-020-01732-3.

Abstract

BACKGROUND

Drug-induced liver injury (DILI) represents an increasing morbidity in the general population, but more so in the elderly cohort of patients. Despite this, the concept of its prevention through prospective analysis has largely remained unexamined. We evaluated the utility of recently validated adverse drug reactions (ADR) avoidability tool in a cohort of elderly patients with DILI.

METHODS

We examined 38 DILI-drug pairs from n=38 patients in a prospective cohort of patients presenting with adverse drug reactions to a Weill Cornell-affiliated tertiary hospital between February 2019 and January 2020. DILI outcomes were adjudicated by the updated Roussel Uclaf Causality Assessment Method (RUCAM). Two clinical pharmacologists and two general physicians utilized the Liverpool adverse drug reactions avoidability tool (LAAT) and the modified Hallas tools to rate the preventability of DILI-drug pairs. Inter-rater, exact agreement proportions, as well as intraclass correlation coefficients were generated and expressed as ordinal outcomes.

RESULTS

The cases examined for the determination of DILI avoidability had probability likelihood of "probable" or "highly probable" by the updated RUCAM scale. Examination of the 38 DILI-drug pairs (n= 38 patients) resulted in a total of 152 ordinal outcome decisions. We found about 32.3% (50/152) and 34.2% (52/152) of DILI-drug pairs were rated as "avoidable" ("probable" or "definite") by the LAAT and the modified Hallas tools respectively. The overall median Krippendorf's kappa with the LAAT was 0.61 (SE 0.12, CI 0.36, 0.85) and for modified Hallas tool was 0.53 (SE 0.18; CI 0.16, 0.89). The inter-rater correlation coefficient (ICC) for the LAAT and modified Hallas were 0.50 [0.32, 0.65] and 0.63 [0.48, 0.76] respectively. Exact pairwise agreement was present in 30/38 (IQR 29.5, 34.5), and 28/38 (IQR 27.5-35.5) of DILI-ADR pairs using the LAAT and modified Hallas tools respectively.

CONCLUSION

We found a significant proportion of drug-induced liver injury adjudicated by the updated RUCAM scale in elderly hospitalized cohort of patients were avoidable with significant implication for therapeutic commissioning as well as cost effectiveness interventions in this cohort of patients.

摘要

背景

药物性肝损伤(DILI)在普通人群中的发病率不断上升,但在老年患者群体中更为明显。尽管如此,通过前瞻性分析来预防 DILI 的概念在很大程度上仍未得到检验。我们评估了最近验证的药物不良反应(ADR)可避免性工具在一组患有 DILI 的老年患者中的效用。

方法

我们检查了 2019 年 2 月至 2020 年 1 月期间在威尔康奈尔附属的三级医院就诊的出现药物不良反应的前瞻性队列中的 38 例 DILI-药物对中的 38 例患者。DILI 结果由更新的 Roussel Uclaf 因果关系评估方法(RUCAM)进行判断。两名临床药理学家和两名普通内科医生使用利物浦药物不良反应可避免性工具(LAAT)和改良 Hallas 工具来评估 DILI-药物对的可预防性。生成了内部评分者之间的一致性比例和组内相关系数,并表示为有序结果。

结果

使用更新的 RUCAM 量表,为确定 DILI 可避免性而检查的病例具有“可能”或“高度可能”的概率。对 38 例 DILI-药物对(n=38 例患者)的检查共产生了 152 个有序结果决策。我们发现,LAAT 和改良 Hallas 工具分别有 32.3%(50/152)和 34.2%(52/152)的 DILI-药物对被评为“可避免”(“可能”或“明确”)。LAAT 的总体中位数 Krippendorf's kappa 值为 0.61(SE 0.12,CI 0.36,0.85),改良 Hallas 工具为 0.53(SE 0.18;CI 0.16,0.89)。LAAT 和改良 Hallas 的内部评分者间相关系数(ICC)分别为 0.50[0.32,0.65]和 0.63[0.48,0.76]。使用 LAAT 和改良 Hallas 工具,DILI-ADR 对中有 30/38(IQR 29.5,34.5)和 28/38(IQR 27.5-35.5)具有确切的配对一致性。

结论

我们发现,在老年住院患者队列中,根据更新的 RUCAM 量表判断的药物性肝损伤中,相当一部分是可以避免的,这对该患者群体的治疗委托以及成本效益干预具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b7/7489200/12ef6e26c826/12877_2020_1732_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验